Can platinum and tungsten disrupt mitochondrial enzymes without urinary metals proving tissue toxicity?

Heavy metals like platinum and tungsten can exert profound biochemical effects at the cellular level, particularly within the mitochondria, but clinical assessments must carefully distinguish cellular mechanisms from systemic diagnostic biomarkers.

Mechanistic pathways of mitochondrial toxicity

• Tungsten antagonism: Tungsten acts as a structural antagonist to molybdenum, competing for insertion into the pyranopterin dithiolene ligand (molybdopterin) biosynthetic machinery. This substitutes molybdenum with tungsten in the active site of mitochondrial molybdenum-cofactor (MoCo) dependent enzymes (such as sulfite oxidase and mARC1/mARC2), rendering them catalytically inactive and disrupting mitochondrial signaling.
• Platinum enzyme and DNA damage: Platinum compounds are metabolized by cysteine S-conjugate β-lyase into highly reactive platinum-thiol species. These species covalently bind and inactivate key tricarboxylic acid (TCA) cycle enzymes (specifically aconitase and the α-ketoglutarate dehydrogenase complex) and directly inhibit electron transport chain complexes I–IV. Furthermore, platinum forms adducts with mitochondrial DNA (mtDNA), suppressing the transcription and replication of essential respiratory chain subunits.

Clinical interpretation of urinary biomarkers

• Exposure vs. toxicity: Standard toxicological guidelines from major public health bodies—including the CDC, ATSDR, and ACMT—establish that elevated urinary concentrations of platinum and tungsten serve strictly as biomarkers of recent systemic exposure and physiological excretion.
• Diagnostic limitations: Finding elevated levels of these metals in urine does not establish a toxicity threshold, correlate with tissue damage, or predict clinical disease. Determining true clinical toxicity requires integrating compatible clinical symptoms and a plausible exposure history. Unvalidated diagnostic methods, such as chelator-provoked urine testing, are discouraged as they drive overdiagnosis.

Bottom line

• While platinum and tungsten directly disrupt vital mitochondrial enzymes and cofactors, elevated urinary levels of these metals indicate exposure or excretion and do not, on their own, prove tissue toxicity or clinical poisoning.